CLINICAL_TRIALS
trial_result
· 2014-01-28
Clinical Trial Update: Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid. [Phase 2]
Summary
Phase II trial evaluating Florbetaben PET imaging (BAY94-9172) for detection/exclusion of cerebral beta-amyloid; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Life Molecular Imaging SA | Conditions: Down Syndrome, Amyloid Beta-protein | Phase 2 | Status: COMPLETED | Results posted: 2014-01-28